33.31  -1.21 (-3.51%)		07-17 16:00
Open: 34.64 High: 34.96 Volume: 241,103		Pre. Close: 34.52 Low: 33.25 Market Cap: 1,350(M)

Short term
Mid term
Targets	6-month :	40.83	1-year :	47.69
Resists	First :	34.95	Second :	40.83
Pivot price	32.8
Supports	First :	32.17	Second :	30.45
MAs	MA(5) :	33.52	MA(20) :	32.43
	MA(100) :	43.59	MA(250) :	40.7
MACD	MACD :	-0.2	Signal :	-0.6
%K %D	K(14,3) :	74.3	D(3) :	71.2
RSI	RSI(14): 50.3
52-week	High :	59.82	Low :	25.26

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ PAHC ] has closed below upper band by 35.6%. Bollinger Bands are 64.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 28 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	34.99 - 35.16	35.16 - 35.28
Low:	32.84 - 33.07	33.07 - 33.21
Close:	32.98 - 33.33	33.33 - 33.55

Phibro Animal Health Corporation operates as a global entity focused on the research, production, and supply of a wide array of animal health and mineral nutrition solutions. While serving a global clientele, its primary market for livestock products is the United States. The company's operations are divided into three main business segments: Animal Health, Mineral Nutrition, and Performance Products. Phibro develops, manufactures, and markets products tailored for various food-producing animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its Animal Health offerings encompass a broad range of pharmaceutical and biological products. These include antimicrobials (both chemical and biological agents) designed to prevent and treat bacterial ailments; anticoccidials, primarily used to control and prevent coccidiosis in poultry and cattle; anthelmintics for combating parasitic intestinal worm infestations; and specific anti-bloat treatments for cattle grazing on legume or wheat pastures. Additionally, the company provides specialized nutritional supplements engineered to enhance animal health and performance, alongside vaccines predominantly for the poultry and swine industries to protect against diseases. The Mineral Nutrition segment focuses on the creation and distribution of various trace mineral formulations and concentrates, featuring elements such as zinc, manganese, copper, iron, and other vital compounds. Furthermore, under its Performance Products segment, Phibro supplies an assortment of specialty ingredients that find application in diverse industries, including personal care, industrial chemicals, and chemical catalysts. Phibro's animal health and mineral nutrition products reach customers through a multi-channel distribution network, including its own local sales offices, direct sales to integrated poultry, swine, and cattle operations, and through commercial animal feed producers, wholesalers, and distributors. The company boasts an extensive international presence, conducting business across the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific region. Initially known as Philipp Brothers Chemicals, Inc., the company adopted the name Phibro Animal Health Corporation in July 2003. It was officially incorporated in 2014 and maintains its corporate headquarters in Teaneck, New Jersey.

Fri, 17 Jul 2026
Phibro Animal Health Corp (PAHC) Shares Fall 3.5% -- GF Value Sa - GuruFocus

Fri, 10 Jul 2026
Phibro Animal Health (PAHC) Bank of America Global Healthcare Conference 2026 summary - Quartr

Fri, 10 Jul 2026
Phibro Animal Health (PAHC) Q1 2025 earnings summary - Quartr

Thu, 09 Jul 2026
Phibro Animal Health (PAHC) Leaves Russell Indexes, Is The Stock A Bargain? - Yahoo Finance

Thu, 09 Jul 2026
Phibro Animal Health (PAHC) Stock Loses Russell Index Spots And Investor Visibility - Yahoo Finance

Thu, 09 Jul 2026
Phibro Animal Health (PAHC) Stock Looks Reasonable On Value But Stretched After 138% Gain - Yahoo Finance

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Shares Out	21 (M)
Shares Float	21 (M)
Held by Insiders	0.8 (%)
Held by Institutions	100.8 (%)
Shares Short	1,220 (K)
Shares Short P.Month	1,100 (K)

EPS	2.32
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	8.92
Profit Margin	6.3 %
Operating Margin	12.5 %
Return on Assets (ttm)	8.3 %
Return on Equity (ttm)	30.3 %
Qtrly Rev. Growth	10.3 %
Gross Profit (p.s.)	23.19
Sales Per Share	71.19
EBITDA (p.s.)	11.14
Qtrly Earnings Growth	15.6 %
Operating Cash Flow	66 (M)
Levered Free Cash Flow	-18 (M)

PE Ratio	14.29
PEG Ratio	1.6
Price to Book value	3.73
Price to Sales	0.46
Price to Cash Flow	10.61

Dividend	0.11
Forward Dividend	0
Dividend Yield	0.3%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.